Director/PDMR Shareholding

RNS Number : 5566G

Standard Life Euro Pri Eqty Tst PLC

02 February 2010

 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

1)    Name of company

Standard Life European Private Equity Trust PLC

2)    State whether notification is in respect of a transaction notified in accordance with DR 3.1.4R(1)(a) or DR 3.1.4R(1)(b) or both

DR 3.1.4R (1) (a)

3)    Name of director/person discharging managerial responsibility

Scott Dobbie - Director

4)    State whether notification relates to a person(s) connected with a person discharging managerial responsibilities/director named in 3 above and identify the connected person(s)

Notification relates to share transactions by Mr Dobbie and his wife. 

5)    Indicate whether notification is in respect of a holding of the person named in 3 or 4 above or in respect of a non-beneficial interest

As in 4

6)    Class of security

Ordinary 0.2p shares

7)    State the nature of the transaction.

Election to receive scrip dividends instead of cash in respect of the final dividend of 0.1p per ordinary share.

8)    Number of shares/amount of stock acquired

150 Ordinary 0.2p shares (75 shares on behalf of Mr Dobbie and 75 shares on behalf of his wife)

9)    Percentage of issued class acquired

0.00009%

10)   Number of shares/amount of stock disposed

-

11)   Percentage of issued class disposed

-

12)   Price per share

99.1p (being the scrip dividend reference price)

13)   Date of transaction

The effective date for issuing the shares in respect of the scrip dividend was 29 January 2010, being the payment date of the final dividend.

14)   Total holding and percentage holding of issued class following this notification

150,150 Ordinary shares, 0.093% of issued class (75,075 shares held by Mr Dobbie and 75,075 shares held by his wife). 

Name of contact and telephone number for queries

Valerie Mackenzie (Tel: [phone])

Date of Notification - 2 February 2010

 

END

 

 

RDSLLFIEFLIFIII